Optimizing Treatment For Geriatric Patients With Cll

Summary

Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses Sameer Parikh, MBBS, explains the challenges in William Wierda, MD, PhD, provides his perspective on the optimal approaches to Watch the full course and our most up-to-date content here: linktr.ee/HealthTreeUniversity Create a free account to track ... Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, shares the results of a study that showed improved overall survival ... In this segment, Javier Pinilla-Ibarz, MD, PhD; William Wierda, MD, PhD; and Jennifer Brown, MD, PhD, describe various ... In this video, a hematology/oncology clinical pharmacy specialist shares her role in providing supportive care for For individuals over 80 years old living with ... survival advantage with obentuzumab directs me to recommend that as the standard first line Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, briefly discusses strategies to William G. Wierda, MD, PhD, professor, Department of Leukemia, Division of Cancer Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the specific considerations for